Holen Sie sich die Stockscreener-App
512.23
0.82%
-4.21
Vorhandelsmarkt:
511.55
-0.68
-0.13%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ISRG?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$516.44
Offen:
$519.21
24-Stunden-Volumen:
1.65M
Relative Volume:
0.91
Marktkapitalisierung:
$183.59B
Einnahmen:
$8.71B
Nettoeinkommen (Verlust:
$2.48B
KGV:
75.11
EPS:
6.82
Netto-Cashflow:
$1.75B
1W Leistung:
-2.86%
1M Leistung:
+0.01%
6M Leistung:
-11.70%
1J Leistung:
+17.15%
1-Tages-Spanne:
$510.84
$521.28
1-Wochen-Bereich:
$508.13
$530.71
52-Wochen-Spanne:
$413.82
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Firmenname
Intuitive Surgical Inc
Sektor
Telefon
(408) 523-2100
Adresse
1020 KIFER ROAD, SUNNYVALE
Vergleichen Sie ISRG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
512.23 | 188.99B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.31 | 50.05B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.95 | 43.06B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
252.01 | 37.62B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.05 | 15.84B | 2.90B | 467.20M | 306.90M | 6.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Hochstufung | Erste Group | Hold → Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Bestätigt | Citigroup | Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-11-17 | Eingeleitet | HSBC Securities | Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-19 | Bestätigt | BTIG Research | Buy |
| 2023-04-19 | Bestätigt | BofA Securities | Buy |
| 2023-04-19 | Bestätigt | Citigroup | Buy |
| 2023-04-19 | Bestätigt | Evercore ISI | In-line |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-19 | Bestätigt | Raymond James | Outperform |
| 2023-04-19 | Bestätigt | Stifel | Buy |
| 2023-04-19 | Bestätigt | Truist | Buy |
| 2023-04-19 | Bestätigt | Wells Fargo | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-23 | Eingeleitet | William Blair | Outperform |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-13 | Eingeleitet | Mizuho | Neutral |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-01-31 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Herabstufung | Redburn | Buy → Neutral |
| 2022-01-21 | Bestätigt | BTIG Research | Buy |
| 2022-01-21 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-01-21 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-21 | Bestätigt | Evercore ISI | In-line |
| 2022-01-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Bestätigt | Piper Sandler | Neutral |
| 2022-01-21 | Bestätigt | Raymond James | Outperform |
| 2022-01-21 | Bestätigt | Robert W. Baird | Outperform |
| 2022-01-21 | Bestätigt | Stifel | Buy |
| 2022-01-21 | Bestätigt | UBS | Neutral |
| 2022-01-21 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-10 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-07-21 | Bestätigt | BofA Securities | Neutral |
| 2021-07-21 | Bestätigt | Citigroup | Buy |
| 2021-07-21 | Bestätigt | JP Morgan | Overweight |
| 2021-07-21 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Bestätigt | Piper Sandler | Neutral |
| 2021-07-21 | Bestätigt | SVB Leerink | Mkt Perform |
| 2021-07-21 | Bestätigt | Stifel | Buy |
| 2021-07-21 | Bestätigt | UBS | Neutral |
| 2021-07-21 | Bestätigt | Wells Fargo | Overweight |
| 2021-07-14 | Bestätigt | Goldman | Buy |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Eingeleitet | Citigroup | Buy |
| 2020-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Eingeleitet | Argus | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-07-20 | Bestätigt | Bernstein | Outperform |
| 2020-04-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Herabstufung | CFRA | Hold → Sell |
| 2020-04-17 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Herabstufung | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Bestätigt | Wells Fargo | Outperform |
| 2019-11-21 | Eingeleitet | Oppenheimer | Perform |
| 2019-07-19 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-22 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-02 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-31 | Bestätigt | Piper Jaffray | Overweight |
| 2018-10-19 | Hochstufung | Canaccord Genuity | Hold → Buy |
Alle ansehen
Intuitive Surgical Inc Aktie (ISRG) Neueste Nachrichten
Medtronic’s Hugo robot wins CE mark for vessel-sealing technology - Yahoo
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It - MSN
FDA Approves Intuitive Surgical (ISRG) Vessel Sealer Curved Surgical Instrument - Insider Monkey
Spine Surgery Robots Market Surging with Minimally Invasive - openPR.com
Intuitive Surgical Price Target Boosted Ahead of Earnings - AInvest
Intuitive Surgical Sees $10.78 Billion Trading Volume Despite 28.74% Decline - AInvest
BTIG Adjusts Price Target on Intuitive Surgical to $566 From $542 - MarketScreener
Why Intuitive Surgical Inc. stock attracts strong analyst attentionFree Predictions - beatles.ru
Hospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG? - Yahoo Finance
FDA Approves Intuitive Surgical’s (ISRG) New Vessel Sealer Tool - MSN
Intuitive Surgical (ISRG) Target Price Boosted Amid MedTech Sect - GuruFocus
FDA clears Intuitive’s Vessel Sealer Curved for use with da Vinci systems - Yahoo
Healthcare Metaverse Market Top PlayersIntuitive Surgical - openPR.com
How to Take Advantage of moves in (ISRG) - news.stocktradersdaily.com
Options Trading Signals for Intuitive Surgical: A Bearish Outlook for the Robotics Company - AInvest
Intuitive Surgical to demolish buildings in Tech Park - Peachtree Corners Magazine
Medical Technology Company Intuitive Expanding in Peachtree Corners, Adding Approximately 1,200 New Jobs - Peachtree Corners Magazine
Surgical Robot Maker to Become City’s Biggest Employer with $540M Campus Expansion - Peachtree Corners Magazine
10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Motley Fool
Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market Today - MSN
RETO files 6-K/A with audited MeinMalzeBier financials & pro forma data | ISRG SEC FilingForm 4 - Stock Titan
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView
Intuitive Surgical Slides Below Key Support—What’s Driving the Drop? - AInvest
Intuitive Surgical: A Leadership That Is Hard To Extirpate (NASDAQ:ISRG) - Seeking Alpha
FDA clears Intuitive curved vessel sealer device for surgical robot - MassDevice
Intuitive Surgical Gets FDA Clearance For Advanced Energy Surgical Instrument: Retail Sentiment Improves - Stocktwits
Intuitive wins FDA nod for Vessel Sealer Curved (ISRG:NASDAQ) - Seeking Alpha
Intuitive Surgical's Vessel Sealer Curved Gets FDA Clearance - Nasdaq
Intuitive Surgical (ISRG) Gains FDA Nod for Innovative Surgical Tool | ISRG Stock News - GuruFocus
Intuitive Receives FDA Clearance for Vessel Sealer Curved, Advancing Robotic-Assisted Surgery Innovation - Quiver Quantitative
Vessel Sealer Curved receives FDA clearance - GlobeNewswire
Breakthrough FDA Clearance: Intuitive's Curved Vessel Sealer Transforms Robotic Surgery Precision - Stock Titan
Intuitive Surgical’s Da Vinci 5 System Receives CE Mark, Expands Advanced Robotic Surgery Access Across Europe - Yahoo Finance
Evercore ISI Lifts Price Target on Intuitive Surgical to $550 From $470, Maintains In Line Rating - MarketScreener
Intuitive Surgical (ISRG) Price Target Raised by Evercore ISI Gr - GuruFocus
ISRG Expands Installed Base, But Is Utilization Keeping Pace? - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights - Nasdaq
Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark - Nasdaq
Intuitive Surgical obtains CE mark for da Vinci 5 robot - The Robot Report
da Vinci 5 Surgical System approved in Europe - Urology Times
Intuitive wins CE mark for da Vinci 5 - MassDevice
Intuitive Announces CE Mark Approval for da Vinci 5 Surgical System in Europe for Minimally Invasive Procedures - Nasdaq
What to Expect From Intuitive Surgical's Next Quarterly Earnings Report - MSN
What To Expect From Intuitive Surgical's Next Quarterly Earnings Report - Barchart.com
Intuitive Surgical, Inc. (ISRG): A Bull Case Theory - Insider Monkey
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing - Nasdaq
Virtual Incision appoints former Intuitive exec as CEO - MedTech Dive
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars? - MarketBeat
ISRG vs BSX: Which Medical Device Stock Has More Room to Run? - The Globe and Mail
Virtual Incision Names Intuitive Veteran Jim Alecxih as CEO - Medical Product Outsourcing
Virtual Incision Appoints Jim Alecxih as Chief Executive Officer - Morningstar
Finanzdaten der Intuitive Surgical Inc-Aktie (ISRG)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):